Training and Continuing Education
An Introduction to the Improved FDA Prescription Drug Labeling - Speaker Biographies
- Activity Description, Learning Objectives, and General Instructions
- Activity Time
- Replacement of CE Statement of Credit/Certificate of Completion (non-CE)
- Download Presentation Transcript
- Download Slides (PDF - 1.8MB)
- Updated Links Within Course
Mary E. Kremzner, Pharm.D., CDR, U.S. Public Health Service
Dr. Kremzner is the Deputy Director of the Division of Drug Information within the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration. In this capacity, she supervises a staff of pharmacists charged with the responsibility of responding to inquiries from a broad range of sources, including regulated industry, academia, consumers, health care professionals and others.
Dr. Kremzner continues to work part-time in a community pharmacy position to maintain her skills as a practicing pharmacist.
Dr. Kremzner received her degrees from the University of Maryland, School of Pharmacy.
Steven F. Osborne, M.D., Medical Officer, Food and Drug Administration
Dr. Osborne is a Medical Officer in the Office of Nonprescription Products within the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration. In this capacity, he reviews new drug applications for over-the-counter drugs and participates in the preparation of final monographs for the over-the-counter drug review.
Prior to joining FDA, Dr. Osborne practiced internal medicine in the private sector and for a HMO. He has organized and participated in medical missions to remote areas of Haiti since 2001.
Dr. Osborne received his undergraduate degree in chemistry from the University of Notre Dame and his medical degree from the Georgetown University School of Medicine.